Literature DB >> 20225219

Efficient synthesis of Fmoc-protected phosphinic pseudodipeptides: Building blocks for the synthesis of matrix metalloproteinase inhibitors.

Manishabrata Bhowmick1, Ravinder R Sappidi, Gregg B Fields, Salvatore D Lepore.   

Abstract

A convenient route for the synthesis of Fmoc-protected phosphinic dipeptide building blocks is described. The protected amino acid isosteres benzyloxycarbonyl aminomethyl phosphinic acid (glycine surrogate), benzyl α-isopropyl acrylate (valine surrogate), and benzyl α-isobutyl acrylate (leucine surrogate) were synthesized starting from commercially available materials. Reaction of either the valine or leucine surrogate with bis(trimethylsilyl) phosphonite generated the pseudodipeptide bond. The synthesis concluded with an efficient one-pot three-step procedure involving a bis-deprotection of the N- and C-termini under catalytic hydrogenation conditions followed by selective capping of the N-terminus with an Fmoc group to yield either Fmoc-NHCH(2) PO(OAd)CH(2) CH(Pr(i) )CO(2) H or Fmoc-NHCH(2) PO(OAd)CH(2) CH(Bu(i) )CO(2) H.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20225219      PMCID: PMC3307803          DOI: 10.1002/bip.21425

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  12 in total

1.  Solid phase combinatorial library of phosphinic peptides for discovery of matrix metalloproteinase inhibitors.

Authors:  J Buchardt; C B Schiødt; C Krog-Jensen; J M Delaissé; N T Foged; M Meldal
Journal:  J Comb Chem       Date:  2000 Nov-Dec

Review 2.  New functions for the matrix metalloproteinases in cancer progression.

Authors:  Mikala Egeblad; Zena Werb
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

3.  Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.

Authors:  Janelle Lauer-Fields; Keith Brew; John K Whitehead; Shunzi Li; Robert P Hammer; Gregg B Fields
Journal:  J Am Chem Soc       Date:  2007-08-02       Impact factor: 15.419

Review 4.  Matrix metalloproteinases as valid clinical targets.

Authors:  Barbara Fingleton
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

5.  Protection of the Hydroxyphosphinyl Function of Phosphinic Dipeptides by Adamantyl. Application to the Solid-Phase Synthesis of Phosphinic Peptides.

Authors:  Athanasios Yiotakis; Stamatia Vassiliou; Jirí Jirácek; Vincent Dive
Journal:  J Org Chem       Date:  1996-09-20       Impact factor: 4.354

Review 6.  Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

Authors:  Christopher M Overall; Oded Kleifeld
Journal:  Nat Rev Cancer       Date:  2006-03       Impact factor: 60.716

7.  Efficient synthesis of enantiomerically pure beta2-amino acids via chiral isoxazolidinones.

Authors:  Hee-Seung Lee; Jin-Seong Park; Byeong Moon Kim; Samuel H Gellman
Journal:  J Org Chem       Date:  2003-02-21       Impact factor: 4.354

8.  Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.

Authors:  S Vassiliou; A Mucha; P Cuniasse; D Georgiadis; K Lucet-Levannier; F Beau; R Kannan; G Murphy; V Knäuper; M C Rio; P Basset; A Yiotakis; V Dive
Journal:  J Med Chem       Date:  1999-07-15       Impact factor: 7.446

9.  Synthesis and biological activity of novel alpha-substituted beta-phenylpropionic acids having pyridin-2-ylphenyl moiety as antihyperglycemic agents.

Authors:  Makoto Takamura; Mitsuya Sakurai; Eriko Yamada; Sachie Fujita; Makoto Yachi; Toshiyuki Takagi; Aya Isobe; Yuka Hagisawa; Toshihiko Fujiwara; Hiroaki Yanagisawa
Journal:  Bioorg Med Chem       Date:  2004-05-01       Impact factor: 3.641

10.  Diastereoselective synthesis of alpha,beta'-disubstituted aminomethyl(2-carboxyethyl)phosphinates as phosphinyl dipeptide isosteres.

Authors:  Takehiro Yamagishi; Hiroyuki Ichikawa; Terumitsu Haruki; Tsutomu Yokomatsu
Journal:  Org Lett       Date:  2008-09-10       Impact factor: 6.005

View more
  7 in total

1.  Stabilization of collagen-model, triple-helical peptides for in vitro and in vivo applications.

Authors:  Manishabrata Bhowmick; Gregg B Fields
Journal:  Methods Mol Biol       Date:  2013

2.  Second Generation Triple-Helical Peptide Inhibitors of Matrix Metalloproteinases.

Authors:  Manishabrata Bhowmick; Dorota Tokmina-Roszyk; Lillian Onwuha-Ekpete; Kelli Harmon; Trista Robichaud; Rita Fuerst; Roma Stawikowska; Bjorn Steffensen; William Roush; Hector R Wong; Gregg B Fields
Journal:  J Med Chem       Date:  2017-04-19       Impact factor: 7.446

3.  Diastereoselective additions of H-phosphinates to alkenyl ketones under phase-transfer conditions.

Authors:  Krishna P Yadavalli; Johannah E Cummines; Chace J Carlisle; Salvatore D Lepore
Journal:  Chem Commun (Camb)       Date:  2022-05-30       Impact factor: 6.065

4.  Synthesis of Fmoc-Gly-Ile Phosphinic Pseudodipeptide: Residue Specific Conditions for Construction of Matrix Metalloproteinase Inhibitor Building Blocks.

Authors:  Manishabrata Bhowmick; Gregg B Fields
Journal:  Int J Pept Res Ther       Date:  2012-12       Impact factor: 1.931

Review 5.  New strategies for targeting matrix metalloproteinases.

Authors:  Gregg B Fields
Journal:  Matrix Biol       Date:  2015-01-14       Impact factor: 11.583

Review 6.  Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases.

Authors:  Gregg B Fields
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

Review 7.  Synthesis and modifications of phosphinic dipeptide analogues.

Authors:  Artur Mucha
Journal:  Molecules       Date:  2012-11-15       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.